Month: May 2020

Clichy, le lundi 25 mai 2020Assemblée Générale Mixte du mardi 30 juin 2020Modalités de mise à disposition des informations relatives à l’Assemblée Générale Mixte des actionnaires du mardi 30 juin 2020.L’avis de réunion a été publié aujourd’hui, le lundi 25 mai 2020, au BALO (Bulletin des Annonces Légales Obligatoires) et contient l’ordre du jour, le projet de résolutions et les principales modalités de participation et de vote à cette Assemblée. Cet avis de réunion, le Rapport du Conseil d’Administration sur le projet de résolutions et les informations légales peuvent être consultés sur le site Internet www.loreal-finance.com (rubriques Information Règlementée / Documentation Assemblée Générale).Les autres documents et renseignements relatifs à cette Assemblée seront tenus à la disposition des actionnaires et consultables sur le site...

New patent granted by the CNIPA is directed at the use of lanifibranor for the treatment of several fibrotic diseases, including NASH, and expires in June 2035The patent expands the existing patent portfolio for lanifibranor in the world’s second largest pharmaceutical market1Daix (France), May 25, 2020 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that the China National Intellectual Property Administration (CNIPA) granted a new patent directed at the use of lanifibranor for the treatment of several fibrotic diseases in China until June 2035.This new patent covers, among others, the use of the Company’s lead product...

 Le nouveau brevet délivré par la CNIPA concerne l’utilisation de lanifibranor pour le traitement de plusieurs maladies fibrotiques, dont la NASH, et expire en juin 2035Ce brevet élargit le portefeuille de brevets existant pour lanifibranor dans le deuxième marché pharmaceutique mondial1Daix (France), le 25 mai 2020 – Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (NASH), des mucopolysaccharidoses (MPS) et d’autres maladies avec un besoin médical non satisfait significatif, annonce aujourd’hui que l’Administration nationale de la propriété intellectuelle de la Chine (China National Intellectual Property Administration – CNIPA) a approuvé un nouveau brevet qui concerne l’utilisation de...

Rovio Entertainment Corporation – Repurchase of own shares on 25 May 2020Rovio Entertainment Corporation                 STOCK EXCHANGE RELEASE                   25 May 2020 AT 18:45 EETIn the Nasdaq HelsinkiDate                                                                                25 May 2020Exchange transaction                                                       BuyShare trading code                                                           ROVIOAmount, shares                                                                24404Average price/share, EUR                                                 5,474606Total cost, EUR                                                                133602,28ROVIO now holds a total of 6 030 498 own shares (ROVIO) including the shares repurchased on 25 May 2020.On behalf of Rovio Entertainment...

Rovio Entertainment Oyj – Omien osakkeiden hankinta 25.05.2020Rovio Entertainment Oyj                             PÖRSSITIEDOTE                  25.05.2020 klo 18.45Helsingin PörssiPäivämäärä                                                25.05.2020Pörssikauppa                                             OstoOsakelaji                                                    ROVIOOsakemäärä                                               24404             osakettaKeskihinta/osake                                        5,474606         euroaKokonaiskustannus                                    133602,28       euroaYhtiön hallussa on 25.05.2020 tehtyjen kauppojen jälkeen 6 030 498 osaketta.Rovio Entertainment Oyj:n puolestaOP Yrityspankki OyjMarko Niemi                                Antti KerätärLisätietoja:Rene Lindell, talousjohtaja+358 207 888 300...

STRATHROY, Ontario, May 25, 2020 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) has today filed its notice of meeting, information circular and other meeting materials (the “Proxy Materials”) on www.sedar.com. Electronic copies of the Proxy Materials are available on the Company’s website at www.evecannabis.ca.Eve & Co will host its annual general meeting in a virtual-only format in response to the ongoing global COVID-19 pandemic. The Meeting is to be held on Thursday June 25, 2020 at 11:00 am Eastern Time and will be hosted virtually at https://web.lumiagm.com/201000707.In order to streamline the virtual meeting process, the Company encourages all shareholders to vote well in advance of the meeting using the Voting Instruction Form or the Form...

NOVA LIMA, Brazil, May 25, 2020 (GLOBE NEWSWIRE) — We are proud to announce that last week AFYA released its 2019 Sustainability Report. The report highlights the Company’s commitment and progress on environmental, social, and governance (ESG) initiatives, ensuring that our major objective is sustained: empower students to transform Brazil leading education, healthcare and technology to the most needed regions.“Afya is a national-scale company with a high socioeconomic impact, because its operations are concentrated in the regions where Brazil most needs education and health services,” said Virgílio Gibbon, Afya’s CEO.In line with the methodology proposed by the Global Reporting Initiative (GRI) – Standard version, Essential option –, Afya classified 10 topics as fundamental, in the current context of the Company, for assuring that...

AttachmentGOFORE_25.5_trades

LiiteGOFORE_25.5_trades

AttachmentVINCIT_25.5_trades